General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Roberts RR et al. – The attributable medical and societal costs of ARI are considerable. Data from this analysis could form the basis for a more comprehensive evaluation of the cost of resistance and the potential economic benefits of prevention programs.

 

Related Articles

Food Safety: Human Health Consequences of Use of Antimicrobial Agents in Aquaculture
Clinical Infectious Diseases, 10/07/09    Relevance Score: 66%

Topical Antimicrobial Therapy for Treating Chronic Wounds
Clinical Infectious Diseases, 10/29/09    Relevance Score: 65%

Hyperbaric oxygen therapy as an anti-infective agent
Expert Review of Anti-infective Therapy, 10/21/09    Relevance Score: 64%

Vaccines and Microbicides Preventing HIV-1, HSV-2, and HPV Mucosal Transmission
Journal of Investigative Dermatology, 10/19/09    Relevance Score: 64%

Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
Clinical Infectious Diseases, 10/29/09    Relevance Score: 62%

Today in Antimicrobials...keeping you current

Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09

The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09

Use of oseltamivir in children
Canadian Family Physician, 12/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address